MDS (MYELODYSPLASTIC SYNDROME)
Clinical trials for MDS (MYELODYSPLASTIC SYNDROME) explained in plain language.
Never miss a new study
Get alerted when new MDS (MYELODYSPLASTIC SYNDROME) trials appear
Sign up with your email to follow new studies for MDS (MYELODYSPLASTIC SYNDROME), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New chemo combo could boost stem cell transplant success for leukemia patients
Disease control Not yet recruitingThis study tests which of two chemotherapy drugs, treosulfan or melphalan, works better and causes fewer side effects when given before a stem cell transplant for people with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). About 220 adults who are already schedule…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Phase: PHASE2 • Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New drug combo may boost stem cell transplant success in hard-to-treat blood cancers
Disease control Not yet recruitingThis study tests whether adding venetoclax to the usual pre-transplant chemotherapy (treosulfan) can safely improve survival for people with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS). About 27 adults aged 18–75 will receive this stronger conditionin…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Phase: PHASE2 • Sponsor: University Hospital Tuebingen • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
CAR-T Follow-Up study aims to track Long-Term effects in blood cancer patients
Knowledge-focused Not yet recruitingThis study follows up with people who have relapsed acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) and received ARD103 CAR-T cells in an earlier trial. Researchers will monitor side effects and overall survival over time to better understand the long-term safety a…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Sponsor: ARCE Therapeutics, Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 02:06 UTC
-
New registry aims to track MDS and its early signs in 500 patients
Knowledge-focused Not yet recruitingThis study creates a registry of 500 adults with myelodysplastic syndromes (MDS) or related blood disorders, including early conditions like CHIP and CCUS. Researchers will collect medical data and blood samples over time to learn how these diseases develop and progress. The goal…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Sponsor: Technische Universität Dresden • Aim: Knowledge-focused
Last updated May 17, 2026 02:05 UTC